Daiichi-Sankyo (South Korea)
Daiichi Sankyo Company, Limited is a global pharmaceutical company and the second-largest pharmaceutical company in Japan. It achieved JPY 1,278 billion in revenue in 2022. The company owns the American pharmaceutical company American Regent. Daiichi Sankyo, Inc. began operating in the U.S. in 2006. Derived from Wikipedia licensed CC-BY-SA.
Open Access statistics for Daiichi-Sankyo (South Korea), South Korea, covering academic research published from 2002 to 2024. Read More.
Open Access Percentage
75%
Total
Publications
282
Total Open
Publications
212
Total
Citations
7.4K
Open Access
Percentage
75%
Total
Publications
282
Total Open
Publications
212
Total
Citations
7.4K
Breakdown
Publisher Open
46%
Both
19%
Other Platform Open
10%
Closed
25%
Percentage of Open Access over time
Publisher Open
Both
Other Platform Open
Closed
Volume of Open Access over time
Open
Closed
Publisher Open
OA Journal 11%
21
Hybrid 25%
46
No Guarantees 64%
117
Other Platform Open
Domain 69%
57
Institution 22%
18
Preprint 20%
17
Other Internet 10%
8
Public 4%
3
Other Platform Locations
Name | Platform Type | Publications |
|---|---|---|
PubMed Central | Domain | 56 |
Europe PMC | Domain | 25 |
Research Square | Preprint | 15 |
DOI | Other Internet | 14 |
University of Southern Denmark - University of Southern Denmark Research Portal | Institution | 4 |
Semantic Scholar | Public | 3 |
California Digital Library - eScholarship | Other Internet | 3 |
Unknown Repository | Other Internet | 2 |
University of Groningen / Centre for Information Technology - University of Groningen research database | Institution | 2 |
University of Edinburgh - Edinburgh Research Explorer | Institution | 2 |